GnTech

GnTech is a biotechnology company based in Florianopolis, Brazil, established in 2012. It specializes in the production of medical reports derived from human genetic sequencing, aiming to enhance the quality of life by facilitating more effective medical treatments through access to high-quality genetic information. The company develops diagnostic and pharmacogenetic tests that inform healthcare providers about hereditary conditions such as heart disease and breast cancer, as well as mental health disorders. These tests offer insights into patient responses to medications, including antidepressants and antipsychotics, thereby providing essential scientific evidence for treatment decisions. GnTech's commitment to high accuracy and clinical applicability positions it as a key player in the biotechnology sector, focusing on improving patient outcomes through genetic analysis.